Select patients with moderate AS may benefit, but in general it’s okay to wait for severe stenosis, Nicolas Van Mieghem says.

Findings from the TAVR UNLOAD study found limited benefits of transcatheter aortic valve replacement (TAVR) in the treatment of heart failure (HF) with reduced ejection fraction (HFrEF) and moderate ...

At baseline, there were 20 patients in NYHA functional class II, 88 patients in functional class III, and 36 patients in functional class IV, 34 patients with right ventricular pacing, and 29 ...

The benefit was confined to symptoms, but in a very sick population with few options, that’s important, say researchers.

Medically reviewed by Richard N. Fogoros, MDMedically reviewed by Richard N. Fogoros, MD Congestive heart failure (CHF) is ...

Dr. Patrick Malecha (Medicine): A 69-year-old man with a history of myocardial infarction, ischemic cardiomyopathy, and an implantable cardioverter–defibrillator (ICD) was evaluated because of ...

Risk for heart failure events is decreased and health status is improved in patients with HFmrEF and HFpEF receiving finerenone.

The mean LVEF was 43% and heart failure was NYHA class III or IV in 86% of patients. The median European System for Cardiac ...

Cash runway is not expected to get Intellia to meaningful data readouts for their Phase III trials. See why NTLA stock is a ...

Results: There were 20, 88, and 36 patients in NYHA functional class II, III, and IV, respectively. Thirty-four patients had right ventricular pacing and another 29 patients had a QRS duration ...

Findings from the TAVR UNLOAD study found limited benefits of transcatheter aortic valve replacement (TAVR) in the treatment ...